Immunopharmacology and immunotoxicology

Keyphrases

Publications

volume 46, number 2, 2024

Gülin Ozdamar Unal, Duygu Kumbul Doğuç, Kuyaş Hekimler Öztürk, Gamze Erkılınç, Feyza Dönmez, Eltaf Doğan Kıran, Ramazan Oğuz Yuceer
The effect of Vortioxetine on the NLRP3 pathway and microglial activity in the prefrontal cortex in an experimental model of depression. Immunopharmacology and immunotoxicology 46 (2) (2024)
Jianfeng Yao, Tao Sun, Songbai Zheng, Jianxia Ma, Qinglian Zeng, Kangwei Liu, Wei Zhang, Yang Yu
The protective effect of teprenone in TNBS-induced ulcerative colitis rats by modulating the gut microbiota and reducing inflammatory response. Immunopharmacology and immunotoxicology 46 (2) (2024)
Jie Xia, Yuan Zhang, Qing Wang, Teng Zhang
Cycloastragenol restrains keratinocyte hyperproliferation by promoting autophagy via the miR-145/STC1/Notch1 axis in psoriasis. Immunopharmacology and immunotoxicology 46 (2) (2024)
Fatemeh Habibi Razi, Razieh Mohammad Jafari, Mohammad Amin Manavi, Mohammad Sheibani, Amir Rashidian, Seyed Mohammad Tavangar, Mohammad Taghi Beighmohammadi, Ahmad Reza Dehpour
Ivermectin ameliorates bleomycin-induced lung fibrosis in male rats by inhibiting the inflammation and oxidative stress. Immunopharmacology and immunotoxicology 46 (2) (2024)
Pengfei Zhu, Xingyu Bi, Dan Su, Xiaoling Li, Bingbing Chen, Juhua Li, Lijiang Zhao, Yaoqing Wang, Suming Xu, Xueqing Wu
Thiolutin, a selective NLRP3 inflammasome inhibitor, attenuates cyclophosphamide-induced impairment of sperm and fertility in mice. Immunopharmacology and immunotoxicology 46 (2) (2024)
Olga Branicka, Radosław Gawlik, Joanna Glück
Eosinophil to lymphocyte ratio may predict OCS reduction and change in quality of life (AQLQ) resulting from asthma biological treatment. Immunopharmacology and immunotoxicology 46 (2) (2024)
Chaochao Wang, Xiaoqiao Cai, Shengfen Lin, Yongqiang Lin
Hydroxychloroquine ameliorates immune functionality and intestinal flora disorders of IgA nephropathy by inhibition of C1GALT1/Cosmc pathway. Immunopharmacology and immunotoxicology 46 (2) (2024)
Weijie Wu, Yan Zhao, Tian Hu, Yan Long, Ya Zeng, Mengling Li, Siyuan Peng, Jinyue Hu, Yueming Shen
Endoplasmic reticulum stress is upregulated in inflammatory bowel disease and contributed TLR2 pathway-mediated inflammatory response. Immunopharmacology and immunotoxicology 46 (2) (2024)
Jianfeng Yao, Tao Sun, Songbai Zheng, Jianxia Ma, Qinglian Zeng, Kangwei Liu, Wei Zhang, Yang Yu
The protective effect of teprenone in TNBS-induced ulcerative colitis rats by modulating the gut microbiota and reducing inflammatory response. Immunopharmacology and immunotoxicology 46 (2) (2024)
Amina Aloui, Jalila Ben Salah-Abbès, Hela Belgacem, Haifa Dhif, Abdellah Zinedine, Amar Riba, Jean Christophe Meile, Noel Durande, Catherine Brabet, Samir Abbès
AFM 1 exposure in male balb/c mice and intervention strategies against its immuno-physiological toxicity using clay mineral and lactic acid bacteria alone or in combination. Immunopharmacology and immunotoxicology 46 (2) (2024)
Gülin Ozdamar Unal, Duygu Kumbul Doğuç, Kuyaş Hekimler Öztürk, Gamze Erkılınç, Feyza Dönmez, Eltaf Doğan Kıran, Ramazan Oğuz Yuceer
The effect of Vortioxetine on the NLRP3 pathway and microglial activity in the prefrontal cortex in an experimental model of depression. Immunopharmacology and immunotoxicology 46 (2) (2024)
Fatemeh Habibi Razi, Razieh Mohammad Jafari, Mohammad Amin Manavi, Mohammad Sheibani, Amir Rashidian, Seyed Mohammad Tavangar, Mohammad Taghi Beighmohammadi, Ahmad Reza Dehpour
Ivermectin ameliorates bleomycin-induced lung fibrosis in male rats by inhibiting the inflammation and oxidative stress. Immunopharmacology and immunotoxicology 46 (2) (2024)
Yaxian Li, Mengdi Ma, Xiaodong Wang, Jing Li, Ziqing Fang, Jianhui Li, Bo Yang, Yida Lu, Xin Xu, Yongxiang Li
Celecoxib alleviates the DSS-induced ulcerative colitis in mice by enhancing intestinal barrier function, inhibiting ferroptosis and suppressing apoptosis. Immunopharmacology and immunotoxicology 46 (2) (2024)
Pengfei Zhu, Xingyu Bi, Dan Su, Xiaoling Li, Bingbing Chen, Juhua Li, Lijiang Zhao, Yaoqing Wang, Suming Xu, Xueqing Wu
Thiolutin, a selective NLRP3 inflammasome inhibitor, attenuates cyclophosphamide-induced impairment of sperm and fertility in mice. Immunopharmacology and immunotoxicology 46 (2) (2024)
Olga Branicka, Radosław Gawlik, Joanna Glück
Eosinophil to lymphocyte ratio may predict OCS reduction and change in quality of life (AQLQ) resulting from asthma biological treatment. Immunopharmacology and immunotoxicology 46 (2) (2024)
Amina Aloui, Jalila Ben Salah-Abbès, Hela Belgacem, Haifa Dhif, Abdellah Zinedine, Amar Riba, Jean Christophe Meile, Noel Durande, Catherine Brabet, Samir Abbès
AFM 1 exposure in male balb/c mice and intervention strategies against its immuno-physiological toxicity using clay mineral and lactic acid bacteria alone or in combination. Immunopharmacology and immunotoxicology 46 (2) (2024)
Yaxian Li, Mengdi Ma, Xiaodong Wang, Jing Li, Ziqing Fang, Jianhui Li, Bo Yang, Yida Lu, Xin Xu, Yongxiang Li
Celecoxib alleviates the DSS-induced ulcerative colitis in mice by enhancing intestinal barrier function, inhibiting ferroptosis and suppressing apoptosis. Immunopharmacology and immunotoxicology 46 (2) (2024)

volume 46, number 3, 2024

Sourav Mondal, Sarthak Saha, Debjeet Sur
Immuno-metabolic reprogramming of T cell: a new frontier for pharmacotherapy of Rheumatoid arthritis. Immunopharmacology and immunotoxicology 46 (3) (2024)
Haiyang Yan, Zhaohui Xing, Shuai Liu, Peng Gao, Guiying Guo
What factors may affect the effect of ICI-combined therapy in patients with metastatic renal cell carcinoma? A meta-analysis. Immunopharmacology and immunotoxicology 46 (3) (2024)
Asmita Parab, Lokesh Kumar Bhatt
T-cell metabolism in rheumatoid arthritis: focus on mitochondrial and lysosomal dysfunction. Immunopharmacology and immunotoxicology 46 (3) (2024)
Yuchen Tao, Tingting Xue, Xiaodong Li, Runjie Guo, Yanlu Wang, Hao Xu, Kexin Hu, Xiaojie Dong, Dongqin Wang, Jianye Ren, Yu Guan, Jiahui Lu
Comparative analysis of immunological changes following realgar and arsenic trioxide treatments in a murine model of myelodysplastic syndrome. Immunopharmacology and immunotoxicology 46 (3) (2024)
Tejal R Waykar, Satish K Mandlik, Deepa S Mandlik
Sirtuins: exploring next-gen therapeutics in the pathogenesis osteoporosis and associated diseases. Immunopharmacology and immunotoxicology 46 (3) (2024)
Swati Mishra, Vishwadeep Shelke, Neha Dagar, Maciej Lech, Anil Bhanudas Gaikwad
Immunosuppressants against acute kidney injury: what to prefer or to avoid? Immunopharmacology and immunotoxicology 46 (3) (2024)
Shuai Geng, Tong Liu, Nan Wang, Xinyue Gao, Xinyu Luo, Ning Shi, Shuai Jiang
Systematic review of the efficacy and safety of lenvatinib in various solid tumors. Immunopharmacology and immunotoxicology 46 (3) (2024)
Mansur Aliyu, Fatema Tuz Zohora, Ayca Ceylan, Fariha Hossain, Reza Yazdani, Gholamreza Azizi
Immunopathogenesis of multiple sclerosis: molecular and cellular mechanisms and new immunotherapeutic approaches. Immunopharmacology and immunotoxicology 46 (3) (2024)
Chaoyun Yin, Yani Pa, Guangyu Li, Qiang Chen, Xizu Wang, Xijun He, Huangao Zhou
Tumor cells inhibit the activation of ILC2s through up-regulating PD-1 expression. Immunopharmacology and immunotoxicology 46 (3) (2024)
Shuai Geng, Tong Liu, Nan Wang, Xinyue Gao, Xinyu Luo, Ning Shi, Shuai Jiang
Systematic review of the efficacy and safety of lenvatinib in various solid tumors. Immunopharmacology and immunotoxicology 46 (3) (2024)
Asmita Parab, Lokesh Kumar Bhatt
T-cell metabolism in rheumatoid arthritis: focus on mitochondrial and lysosomal dysfunction. Immunopharmacology and immunotoxicology 46 (3) (2024)
Sourav Mondal, Sarthak Saha, Debjeet Sur
Immuno-metabolic reprogramming of T cell: a new frontier for pharmacotherapy of Rheumatoid arthritis. Immunopharmacology and immunotoxicology 46 (3) (2024)
Swati Mishra, Vishwadeep Shelke, Neha Dagar, Maciej Lech, Anil Bhanudas Gaikwad
Immunosuppressants against acute kidney injury: what to prefer or to avoid? Immunopharmacology and immunotoxicology 46 (3) (2024)
Haiyang Yan, Zhaohui Xing, Shuai Liu, Peng Gao, Guiying Guo
What factors may affect the effect of ICI-combined therapy in patients with metastatic renal cell carcinoma? A meta-analysis. Immunopharmacology and immunotoxicology 46 (3) (2024)
Mansur Aliyu, Fatema Tuz Zohora, Ayca Ceylan, Fariha Hossain, Reza Yazdani, Gholamreza Azizi
Immunopathogenesis of multiple sclerosis: molecular and cellular mechanisms and new immunotherapeutic approaches. Immunopharmacology and immunotoxicology 46 (3) (2024)
Ruixuan Li, Ying Liu, Jianfeng Liu, Bo Chen, Zhongjie Ji, Aixia Xu, Tianhua Zhang
CCL2 regulated by the CTBP1-AS2/miR-335-5p axis promotes hemangioma progression and angiogenesis. Immunopharmacology and immunotoxicology 46 (3) (2024)
Jia Jian, Li Yu-Qing, Han Rang-Yue, Zhong Xia, Xie Ke-Huan, Yan Ying, Wang Li, Tan Rui-Zhi
Isorhamnetin ameliorates cisplatin-induced acute kidney injury in mice by activating SLPI-mediated anti-inflammatory effect in macrophage. Immunopharmacology and immunotoxicology 46 (3) (2024)
Tejal R Waykar, Satish K Mandlik, Deepa S Mandlik
Sirtuins: exploring next-gen therapeutics in the pathogenesis osteoporosis and associated diseases. Immunopharmacology and immunotoxicology 46 (3) (2024)

volume 46, number 4, 2024

Xinyao Liu, Lulu Zang, Jiabao Yu, Jinjin Yu, Siqi Wang, Lili Zhou, Huixin Song, Yajing Ma, Xiaofeng Niu, Weifeng Li
Anti-inflammatory effect of proanthocyanidins from blueberry through NF-κβ/NLRP3 signaling pathway in vivo and in vitro . Immunopharmacology and immunotoxicology 46 (4) (2024)
Wen-Chien Cheng, Pei Ying Chen, Xiang Zhang, Yu-Kang Chang, Kok-Tong Tan, Tim C C Lin
5,7,3',4'-Tetramethoxyflavone suppresses TGF-β1-induced activation of murine fibroblasts in vitro and ameliorates bleomycin-induced pulmonary fibrosis in mice. Immunopharmacology and immunotoxicology 46 (4) (2024)
Risa Okamoto, Yoshitaka Hosokawa, Ikuko Hosokawa, Kazumi Ozaki, Keiichi Hosaka
Cardamonin inhibits the expression of inflammatory mediators in TNF-α-stimulated human periodontal ligament cells. Immunopharmacology and immunotoxicology 46 (4) (2024)
Jimmy Ming-Jung Chuang, Hsien-Lin Chen, Chi-I Chang, Jia-Syuan Lin, Hui-Min Chang, Wan-Ju Wu, Mei-Ying Lin, Wu-Fu Chen, Chien-Hsing Lee
Nobiletin derivative, 5-acetoxy-6,7,8,3',4'-pentamethoxyflavone, inhibits neuroinflammation through the inhibition of TLR4/MyD88/MAPK signaling pathways and STAT3 in microglia. Immunopharmacology and immunotoxicology 46 (4) (2024)
Akshit Sinha, Supriya Roy
Prospective therapeutic targets and recent advancements in the treatment of inflammatory bowel disease. Immunopharmacology and immunotoxicology 46 (4) (2024)
Ehab A M El-Shoura, Souty M Z Sharkawi, Lobna A Abdelzaher, Basel A Abdel-Wahab, Yasmine H Ahmed, Asmaa Ramadan Abdel-Sattar
Reno-protective effect of fenofibrate and febuxostat against vancomycin-induced acute renal injury in rats: Targeting PPARγ/NF-κB/COX-II and AMPK/Nrf2/HO-1 signaling pathways. Immunopharmacology and immunotoxicology 46 (4) (2024)
Shweta Shrivastava, Tribhuwan Bahuguna, Sudipto Mondal, Sunil Kumar, Bijo Mathew, Manish Kumar Jeengar, V G M Naidu
Attenuation of adjuvant-induced arthritis with carnosic acid by inhibiting mPGES-1, COX-2, and bone loss in male SD rats. Immunopharmacology and immunotoxicology 46 (4) (2024)
Mohammad Aadil Bhat, Supriya Roy, Suneela Dhaneshwar, Swatantra Kumar, Shailendra K Saxena
Desloratadine via its anti-inflammatory and antioxidative properties ameliorates TNBS-induced experimental colitis in rats. Immunopharmacology and immunotoxicology 46 (4) (2024)
Nahed Abdel-Aziz, Mostafa Saif-Elnasr
Citicoline modulates inflammatory signaling pathways in the spleen of rats exposed to gamma-radiation. Immunopharmacology and immunotoxicology 46 (4) (2024)
Dan Li, Song Shan, Xuhua Mao, Yiru Zhao, Beizhong Chen, Qiuyun Xiong, Desi Pan, Shengjian Huang
CS12192, a novel JAK3/JAK1/TBK1 inhibitor, attenuates autoimmune dermatoses in murine models. Immunopharmacology and immunotoxicology 46 (4) (2024)
Isabela Gonçalves Lima, Isabele Benck Usiro Cabral da Silva, Vitória Carpentieri Pípolo, Vinicius Daher Alvares Delfino, Paulo Roberto Bignardi
Acute kidney injury associated with anti-PD-1 and anti-PD-L1 drugs: a meta-analysis of randomized clinical trials. Immunopharmacology and immunotoxicology 46 (4) (2024)
Ehab A M El-Shoura, Souty M Z Sharkawi, Lobna A Abdelzaher, Basel A Abdel-Wahab, Yasmine H Ahmed, Asmaa Ramadan Abdel-Sattar
Reno-protective effect of fenofibrate and febuxostat against vancomycin-induced acute renal injury in rats: Targeting PPARγ/NF-κB/COX-II and AMPK/Nrf2/HO-1 signaling pathways. Immunopharmacology and immunotoxicology 46 (4) (2024)
Risa Okamoto, Yoshitaka Hosokawa, Ikuko Hosokawa, Kazumi Ozaki, Keiichi Hosaka
Cardamonin inhibits the expression of inflammatory mediators in TNF-α-stimulated human periodontal ligament cells. Immunopharmacology and immunotoxicology 46 (4) (2024)
Xiaoqing Zhao, Xinglan Huang, Caifeng Huang, Xingrong Wang, Yuqi Yang, Ruonan Dang, Suiying Zhang, Yuqiong Deng, Peng Yan, Yiye Zhou, Ping Fan, Xiping Cheng
Study on the mechanism of glucocorticoid receptor mitochondrial translocation and glucocorticoid-induced apoptosis in macrophages. Immunopharmacology and immunotoxicology 46 (4) (2024)
Sümeyye Kemaneci, Alev Keser, Özlem Özmen
Is resveratrol really effective in kidney disease?: A different perspective than ever before. Immunopharmacology and immunotoxicology 46 (4) (2024)